Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT07483294

Cerebellum-based Imaging Neural Markers for Antipsychotic Response

Sponsor: Northwell Health

View on ClinicalTrials.gov

Summary

This study will investigate neural markers in the cerebellar-cortical circuitry that predict treatment response to antipsychotics in first-episode psychosis. A total of 120 patients diagnosed with a first-episode psychotic disorder will be recruited. All subjects receive naturalistic treatment with either risperidone or aripiprazole for 12 weeks, with dosage and titration followed by standard clinical care. A comprehensive clinical and neuroimaging assessments will be performed before and after treatment.

Official title: Cerebellar-cortical Circuitry and Prediction of Treatment Response in Early Psychosis

Key Details

Gender

All

Age Range

16 Years - 40 Years

Study Type

OBSERVATIONAL

Enrollment

120

Start Date

2025-11-01

Completion Date

2030-06-01

Last Updated

2026-04-06

Healthy Volunteers

No

Interventions

DRUG

Risperidone

Naturalistic treatment

Locations (1)

Zucker Hillside Hospital

Glen Oaks, New York, United States